Replies to post #63284 on NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Those are very big facilities...

But I really can't see how anyone can justify $170mm, and $100mm of that in cash (the rest shares and warrants) to Cognate for their services. I can look at peers doing more for far less. I actually wouldn't think it nearly as bad, and maybe not bad at all if Cognate was a subsidiary, but of course they're not. Actually they own NWBO but not the other way around. Lol so weird...

Oh well whatever. I'm just talking ;)

[Doc logic]

Rkmatters,

BINGO!!! As I said before to another poster, it's best to keep an eye on manufacturing developments. Commitment to manufacturing is how the Europeans weed out good prospects from poorer ones. FDA by itself will allow some flexibility with proof of potential to ramp up. With a multi continent strategy in place the stricter European requirements are being follwed.